Cts Q3 2026 earnings
Record profitability and margins with sales growth and guidance raised.
Headline numbers
| Metric | Actual | YoY | QoQ | 8-K location |
|---|---|---|---|---|
| Revenue | $149.6M | +5% | — | Ex. 99.1, income statement |
| EPS (GAAP) | $0.61 | +15 cents | — | Ex. 99.1, income statement |
| EPS (adjusted) | $0.77 | +17 cents | — | Ex. 99.1, income statement |
| Net income | $17.8M | +29.7% | — | Ex. 99.1, income statement |
| Adj. EBITDA margin | 24.7% | +90 bps | — | Ex. 99.1, income statement |
Revenue breakdown
| Segment | Actual | YoY | Share of revenue | Note |
|---|---|---|---|---|
| Diversified end-markets | $149.6M | +7% | 60% | Industrial, aerospace & defense, and medical |
| Transportation | $149.6M | +2% | 40% | — |
Margins and costs
- Gross margin 42.2% (prior 38.9%, change +330 bps)
- Operating expenses $37.1M (+13.4% YoY)
- One-offs in the quarter Restructuring charges $0.5M; Environmental charges $0.2M; Acquisition-related adjustments $1.2M; Insurance recovery -$12.5M; Foreign currency loss $0.1M
- Effective tax rate 53.5% (prior-year 30.6%, year-to-date 37.1%)
- Non-GAAP bridge Adds back restructuring, environmental, acquisition-related, insurance recovery, and foreign currency items to GAAP net earnings.
KPIs
| Metric | Actual | Prior quarter | Prior year | Change |
|---|---|---|---|---|
| Operating cash flow | $43.5M | — | $29.0M | +$14.5M |
| Free cash flow | $41.1M | — | $24.2M | +$16.9M |
| Controllable working capital as % of annualized sales | 17.5% | 16.1% | 16.9% | +0.4 pp |
Guidance
| Metric | Guide | Prior guide | Change |
|---|---|---|---|
| 2026 Sales | $580-$590M | $565-$585M | +$15M |
| 2026 Adjusted diluted EPS | $2.78-$2.88 | $2.55-$2.70 | +$0.23 |
What drove it
- Revenue story Sales increased 5% YoY, driven by 7% growth in diversified end-markets and 2% growth in transportation.
- EPS story EPS increased 15 cents YoY on higher net income and margin expansion.
- One-off check Insurance recovery of $12.5M in Q3 2026, a non-recurring item.
The good
- Record adjusted gross margin of 42.2%
- Record adjusted EBITDA margin of 24.7%
- Operating cash flow up $14.5M YoY
The bad
- Transportation sales growth remains modest at 2%
The ugly
- none
Open questions
- The impact of the Millar acquisition on financials is not yet reflected in the reported figures.
- The filing does not provide a reconciliation of forward-looking adjusted diluted EPS to GAAP.
Full release
Earnings: CTS — filed 2026-10-27
CTS Announces Third Quarter 2026 Results
2026 Outlook Raised on Record Profitability; Millar Acquisition Advances Diversification
Lisle, Ill. -
CTS Corporation (NYSE: CTS), a leading global designer and manufacturer of highly engineered solutions that “Sense, Connect and Move,” today announced results for the third quarter of 2026.
“CTS delivered another strong quarter, with sales increasing 5% year over year, driven by continued strength across our increasingly diversified portfolio. Diversified end-market sales grew 7% and now represent 60% of total sales, while Transportation sales also posted modest growth.” said Pratik Trivedi, CEO of CTS Corporation. “Our disciplined execution is delivering profitable growth, record margins and strong cash generation. The acquisition of Millar further advances our diversification strategy, especially in the medical end market, and enhances our opportunity to create sustainable long-term value.”
Third Quarter 2026 Results
• Sales were $149.6 million in the third quarter of 2026, up 5% year-over-year. Sales to diversified end-markets increased 7%. Sales to the transportation market increased 2%.
• Net income was $17.8 million, or 11.9% of sales, compared to $13.7 million, or 9.6% of sales in the third quarter of 2025.
• Diluted EPS was $0.61, up 15 cents from $0.46 in the third quarter of 2025.
• Adjusted Gross margin was 42.2%, up 330 bps from 38.9% in the third quarter of 2025.
• Adjusted EBITDA margin was 24.7%, up 90 bps from 23.8% in the third quarter of 2025.
• Adjusted diluted EPS was $0.77, up 17 cents from $0.60 in the third quarter of 2025.
• Operating cash flow was $43.5 million, up $14.5 million from $29.0 million in the third quarter of 2025.
2026 Guidance
Assuming the continuation of current market conditions, CTS is increasing its previous guidance of 2026 sales from a range of $565-$585 million to $580-$590 million and adjusted diluted EPS from a range of $2.55-$2.70 to $2.78-$2.88. www.ctscorp.com
CTS does not provide reconciliations of forward-looking non-GAAP financial measures, such as estimated adjusted diluted earnings per share, to the most comparable GAAP financial measures on a forward-looking basis because CTS is unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of certain items, such as, but not limited to, restructuring costs, environmental remediation costs, acquisition-related costs, foreign exchange rates and other non-routine costs. Each of such adjustments has not yet occurred, are out of CTS' control and/or cannot be reasonably predicted. For the same reasons, CTS is unable to address the probable significance of the unavailable information.
Conference Call and Supplemental Materials
As previously announced, CTS has scheduled a conference call for 10:00 a.m. (ET) today.The conference call can be accessed by registering online at CTS Corporation
Q3 2026 Earnings Call, at which time registrants will receive dial-in information as well as a conference ID. In addition, CTS will be using a supplemental slide presentation that will be referred to during the call. The presentation and a live audio webcast of the conference call will be available and can be accessed directly from CTS’ website at https://investors.ctscorp.com/news-events/events-and-presentations/.
Any replay, rebroadcast, transcript or other reproduction or transmission of this conference call, other than the replay accessible through the website noted above, has not been authorized by CTS and is strictly prohibited. Investors should be aware that any unauthorized reproduction of this conference call may not be an accurate reflection of its contents.
About CTS
CTS Corporation (NYSE: CTS) is a leading designer and manufacturer of products that Sense, Connect and Move. CTS manufactures sensors, actuators and electronic components in North America, Europe and Asia, and provides engineered products to customers in the aerospace & defense, industrial, medical and transportation markets. For more information, visit www.ctscorp.com/.
Diversified end markets, previously referred as the “non-transportation” market, includes the industrial, aerospace & defense, and medical end markets. www.ctscorp.com
Financial statements
Income Statement
Three Months Ended — (In thousands, except per share amounts)
| Three Months Ended – September 30, 2026 | Three Months Ended – September 30, 2025 | Nine Months Ended – September 30, 2026 | Nine Months Ended – September 30, 2025 | ||
|---|---|---|---|---|---|
| Net sales | 149,583 | 142,970 | 433,593 | 404,047 | |
| Cost of goods sold | 86,431 | 87,629 | 255,407 | 249,727 | |
| Gross margin | 63,152 | 55,341 | 178,186 | 154,320 | |
| Selling, general and administrative expenses | 30,812 | 27,222 | 85,185 | 73,922 | |
| Research and development expenses | 6,333 | 6,901 | 17,730 | 19,416 | |
| Restructuring charges | 468 | 280 | 948 | 1,028 | |
| Operating earnings | 25,539 | 20,938 | 74,323 | 59,954 | |
| Other (expense) income: | Interest expense | -630 | -1,110 | -2,042 | -3,398 |
| Other (expense) income: | Interest income | 782 | 535 | 1,832 | 1,603 |
| Other (expense) income: | Other income (expense), net | 12,534 | -643 | 12,023 | 665 |
| Other (expense) income: | Total other income (expense), net | 12,686 | -1,218 | 11,813 | -1,130 |
| Other (expense) income: | Earnings before income taxes | 38,225 | 19,720 | 86,136 | 58,824 |
| Other (expense) income: | Income tax expense | 20,468 | 6,033 | 32,018 | 13,243 |
| Other (expense) income: | Net earnings | 17,757 | 13,687 | 54,118 | 45,581 |
| Earnings per share: | Basic | 0.62 | 0.47 | 1.89 | 1.53 |
| Earnings per share: | Diluted | 0.61 | 0.46 | 1.87 | 1.52 |
| Earnings per share: | Basic weighted – average common shares outstanding: | 28,547 | 29,348 | 28,605 | 29,698 |
| Earnings per share: | Effect of dilutive securities | 370 | 279 | 342 | 281 |
| Earnings per share: | Diluted weighted – average common shares outstanding: | 28,917 | 29,627 | 28,947 | 29,979 |
| Earnings per share: | Cash dividends declared per share | 0.04 | 0.04 | 0.12 | 0.12 |
Income Statement
Three Months Ended September 30, — Adjusted EBITDA Margin
| Three Months Ended September 30, – 2026 | Three Months Ended September 30, – 2025 | Nine Months Ended September 30, – 2026 | Nine Months Ended September 30, – 2025 | Twelve Months Ended December 31, – 2025 | Twelve Months Ended December 31, – 2024 | Twelve Months Ended December 31, – 2023 | ||
|---|---|---|---|---|---|---|---|---|
| Net earnings | 17.8 | 13.7 | 54.1 | 45.6 | 65.3 | 55.5 | 60.5 | |
| Net sales | 149.6 | 143 | 433.6 | 404 | 541.3 | 514.8 | 550.4 | |
| Net earnings margin | 11.9% | 9.6 | 12.5% | 11.3 | 12.1% | 10.8% | 11 | |
| Depreciation and amortization expense | 8.7 | 8.8 | 26.3 | 25.9 | 34.5 | 30.9 | 28.7 | |
| Interest expense | 0.6 | 1.1 | 2 | 3.4 | 4.3 | 4.2 | 3.3 | |
| Tax expense | 20.5 | 6 | 32 | 13.2 | 18.5 | 13.1 | 14.6 | |
| EBITDA | 47.6 | 29.7 | 114.5 | 88.1 | 122.6 | 103.7 | 107.2 | |
| EBITDA Margin | 31.8% | 20.7 | 26.4% | 21.8 | 22.6% | 20.1% | 19.5 | |
| Adjustments to EBITDA: | Restructuring charges (c) | 0.5 | 0.3 | 0.9 | 1 | 1.4 | 4.7 | 7.1 |
| Adjustments to EBITDA: | Restructuring-related charges (b) | 0.1 | 0.4 | 0.2 | 0.4 | 0.7 | 0.7 | 0.6 |
| Adjustments to EBITDA: | Environmental charges (a) | 0.2 | 4.2 | 0.9 | 4.7 | 5.5 | 1.6 | 3.5 |
| Adjustments to EBITDA: | Acquisition-related adjustments (a) | 1.2 | -1.1 | 1.3 | -2.6 | -5.6 | -0.3 | 0.4 |
| Adjustments to EBITDA: | Inventory fair value step-up (b) | 2.1 | ||||||
| Adjustments to EBITDA: | Non-cash pension and related expense (d) | 0.1 | 0.1 | 0.2 | ||||
| Adjustments to EBITDA: | Foreign currency loss (gain) (d) | -0.1 | 0.6 | 0.4 | -0.7 | -1.3 | 2.7 | 2 |
| Adjustments to EBITDA: | Insurance recovery (d) | -12.5 | -12.5 | |||||
| Adjustments to EBITDA: | Total adjustments to EBITDA | -10.6 | 4.4 | -8.7 | 2.8 | 0.9 | 11.7 | 13.6 |
| Adjustments to EBITDA: | Adjusted EBITDA | 37 | 34.1 | 105.7 | 90.9 | 123.4 | 115.4 | 120.7 |
| Adjustments to EBITDA: | Adjusted EBITDA Margin | 24.7% | 23.8 | 24.4% | 22.5 | 22.8% | 22.4% | 21.9 |
Income Statement
Three Months Ended September 30, — Adjusted Net Earnings and Adjusted Diluted Earnings Per Share
| Three Months Ended September 30, – 2026 | Three Months Ended September 30, – 2026 – Per share | Three Months Ended September 30, – 2025 | Three Months Ended September 30, – 2025 – Per share | Nine Months Ended September 30, – 2026 | Nine Months Ended September 30, – 2026 – Per share | Nine Months Ended September 30, – 2025 | Nine Months Ended September 30, – 2025 – Per share | ||
|---|---|---|---|---|---|---|---|---|---|
| Net earnings (A) | 17.8 | 0.61 | 13.7 | 0.46 | 54.1 | 1.87 | 45.6 | 1.52 | |
| Adjustments to reported net earnings: | Restructuring charges (c) | 0.5 | 0.02 | 0.3 | 0.01 | 0.9 | 0.03 | 1 | 0.03 |
| Adjustments to reported net earnings: | Restructuring-related charges (a) | 0.1 | 0 | 0.4 | 0.01 | 0.2 | 0.01 | 0.4 | 0.01 |
| Adjustments to reported net earnings: | Environmental charges (a) | 0.2 | 0.01 | 4.2 | 0.14 | 0.9 | 0.03 | 4.7 | 0.16 |
| Adjustments to reported net earnings: | Acquisition-related adjustments (a) | 1.2 | 0.04 | -1.1 | -0.03 | 1.3 | 0.05 | -2.6 | -0.09 |
| Adjustments to reported net earnings: | Non-cash pension and related expense (d) | 0.1 | |||||||
| Adjustments to reported net earnings: | Foreign currency loss (gain) (d) | -0.1 | 0 | 0.6 | 0.02 | 0.4 | 0.01 | -0.7 | -0.02 |
| Adjustments to reported net earnings: | Insurance recovery (d) | -12.5 | -0.43 | -12.5 | -0.43 | ||||
| Adjustments to reported net earnings: | Total pretax adjustments to reported net earnings | -10.6 | -0.37 | 4.4 | 0.15 | -8.7 | -0.3 | 2.8 | 0.09 |
| Adjustments to reported net earnings: | Income tax effect of above adjustments (f) | 2.5 | 0.09 | -1 | -0.03 | 2.2 | 0.08 | -1 | -0.03 |
| Adjustments to reported net earnings: | Total adjustments, tax affected (f) (B) | -8.1 | -0.28 | 3.4 | 0.12 | -6.5 | -0.23 | 1.8 | 0.06 |
| Tax adjustments: | Other discrete tax items (e) | 12.7 | 0.44 | 0.7 | 0.02 | 14 | 0.48 | 0.8 | 0.03 |
| Tax adjustments: | Total tax adjustments (C) | 12.7 | 0.44 | 0.7 | 0.02 | 14 | 0.48 | 0.8 | 0.03 |
| Tax adjustments: | Adjusted net earnings (A+B+C) and Adjusted net earnings per share | 22.4 | 0.77 | 17.8 | 0.6 | 61.6 | 2.13 | 48.2 | 1.61 |
| Tax adjustments: | Net sales | 149.6 | 143 | 433.6 | 404 |
Income Statement
Twelve Months Ended December 31, — Adjusted Net Earnings and Adjusted Diluted Earnings Per Share
| Twelve Months Ended December 31, – 2025 | Twelve Months Ended December 31, – 2025 – Per share | Twelve Months Ended December 31, – 2024 | Twelve Months Ended December 31, – 2024 – Per share | Twelve Months Ended December 31, – 2023 | Twelve Months Ended December 31, – 2023 – Per share | ||
|---|---|---|---|---|---|---|---|
| Net earnings (A) | 65.3 | 2.19 | 55.5 | 1.8 | 60.5 | 1.92 | |
| Adjustments to reported net earnings: | Restructuring charges (c) | 1.4 | 0.05 | 4.7 | 0.15 | 7.1 | 0.22 |
| Adjustments to reported net earnings: | Restructuring-related charges (a) | 0.7 | 0.02 | 0.7 | 0.02 | 0.6 | 0.02 |
| Adjustments to reported net earnings: | Environmental charges (a) | 5.5 | 0.18 | 1.6 | 0.05 | 3.5 | 0.11 |
| Adjustments to reported net earnings: | Acquisition-related adjustments (a) | -5.6 | -0.19 | -0.3 | -0.01 | 0.4 | 0.01 |
| Adjustments to reported net earnings: | Inventory fair value step-up (b) | 2.1 | 0.07 | ||||
| Adjustments to reported net earnings: | Non-cash pension and related expense (d) | 0.1 | 0 | 0.2 | 0.01 | ||
| Adjustments to reported net earnings: | Foreign currency (gain) loss (d) | -1.3 | -0.04 | 2.7 | 0.09 | 2 | 0.06 |
| Adjustments to reported net earnings: | Total pretax adjustments to reported net earnings | 0.9 | 0.03 | 11.7 | 0.38 | 13.5 | 0.42 |
| Adjustments to reported net earnings: | Income tax effect of above adjustments (f) | -0.6 | -0.02 | -2.2 | -0.07 | -2.4 | -0.07 |
| Adjustments to reported net earnings: | Total adjustments, tax affected (f) (B) | 0.3 | 0.01 | 9.5 | 0.31 | 11.1 | 0.35 |
| Tax adjustments: | Other discrete tax items (e) | 0.8 | 0.03 | 0.3 | 0.01 | -1.6 | -0.05 |
| Tax adjustments: | Total tax adjustments (C) | 0.8 | 0.03 | 0.3 | 0.01 | -1.6 | -0.05 |
| Tax adjustments: | Adjusted net earnings (A+B+C) and Adjusted net earnings per share | 66.3 | 2.23 | 65.3 | 2.12 | 70 | 2.22 |
| Tax adjustments: | Net sales | 541.3 | 514.8 | 550.4 | |||
| Tax adjustments: | Net earnings as a % of net sales | 12.1% | 10.8% | 11.0% | |||
| Tax adjustments: | Adjusted net earnings as a % of net sales | 12.3% | 12.7% | 12.7% |
Balance Sheet
December 31, 2025 — (In thousands of dollars) (in thousands)
| (Unaudited) September 30, 2026 | December 31, 2025 | ||
|---|---|---|---|
| Current Assets | Cash and cash equivalents | 143,880 | 82,295 |
| Current Assets | Accounts receivable, net of allowances of $584 and $910, respectively | 93,007 | 88,096 |
| Current Assets | Inventories, net | 62,355 | 52,854 |
| Current Assets | Other current assets | 29,704 | 29,461 |
| Current Assets | Total current assets | 328,946 | 252,706 |
| Current Assets | Property, plant and equipment, net | 86,637 | 89,741 |
| Current Assets | Operating lease assets, net | 31,016 | 22,542 |
| Other Assets | Goodwill | 207,395 | 209,611 |
| Other Assets | Other intangible assets, net | 139,535 | 153,562 |
| Other Assets | Deferred income taxes | 17,739 | 25,110 |
| Other Assets | Other assets | 10,826 | 11,039 |
| Other Assets | Total other assets | 375,495 | 399,322 |
| Other Assets | Total Assets | 822,094 | 764,311 |
| Current Liabilities | Accounts payable | 50,582 | 48,220 |
| Current Liabilities | Operating lease obligations | 4,355 | 3,453 |
| Current Liabilities | Accrued payroll and benefits | 22,699 | 20,732 |
| Current Liabilities | Accrued expenses and other liabilities | 49,205 | 37,283 |
| Current Liabilities | Total current liabilities | 126,841 | 109,688 |
| Current Liabilities | Long-term debt | 55,000 | 57,500 |
| Current Liabilities | Long-term operating lease obligations | 29,412 | 21,841 |
| Current Liabilities | Long-term pension obligations | 3,656 | 3,698 |
| Current Liabilities | Deferred income taxes | 13,163 | 12,800 |
| Current Liabilities | Other long-term obligations | 7,298 | 6,998 |
| Current Liabilities | Total Liabilities | 235,370 | 212,525 |
| Shareholders’ Equity | Common stock | 326,888 | 324,982 |
| Shareholders’ Equity | Additional contributed capital | 46,043 | 43,303 |
| Shareholders’ Equity | Retained earnings | 764,156 | 713,467 |
| Shareholders’ Equity | Accumulated other comprehensive income | 8,701 | 13,748 |
| Shareholders’ Equity | Total shareholders’ equity before treasury stock | 1,145,788 | 1,095,500 |
| Shareholders’ Equity | Treasury stock | -559,064 | -543,714 |
| Shareholders’ Equity | Total shareholders’ equity | 586,724 | 551,786 |
| Shareholders’ Equity | Total Liabilities and Shareholders’ Equity | 822,094 | 764,311 |
Balance Sheet
September 30, — Controllable Working Capital
| September 30, – 2026 | September 30, – 2025 | December 31, – 2025 | December 31, – 2024 | December 31, – 2023 | |
|---|---|---|---|---|---|
| Net accounts receivable | 93 | 85.9 | 88.1 | 77.6 | 78.6 |
| Net inventory | 62.4 | 54.2 | 52.9 | 52.3 | 60 |
| Accounts payable | -50.6 | -48.1 | -48.2 | -42.6 | -43.5 |
| Controllable working capital | 104.8 | 92 | 92.7 | 87.3 | 95.1 |
| Quarter sales | 149.6 | 143 | 137.3 | 126.4 | 124.7 |
| Multiplied by 4 | 4 | 4 | 4 | 4 | 4 |
| Annualized sales | 598.3 | 571.9 | 549.1 | 505.6 | 498.8 |
| Controllable working capital as a % of annualized sales | 17.5% | 16.1 | 16.9% | 17.3% | 19.1 |
Cash Flow
Three Months Ended September 30, — Free Cash Flow
| Three Months Ended September 30, – 2026 | Three Months Ended September 30, – 2025 | Nine Months Ended September 30, – 2026 | Nine Months Ended September 30, – 2025 | Twelve Months Ended December 31, – 2025 | Twelve Months Ended December 31, – 2024 | Twelve Months Ended December 31, – 2023 | |
|---|---|---|---|---|---|---|---|
| Net cash provided by operating activities | 43.5 | 29 | 94.3 | 72.9 | 102.1 | 98.2 | 88.8 |
| Capital expenditures | -2.4 | -4.8 | -12 | -12.5 | -15.7 | -18.6 | -14.7 |
| Free cash flow | 41.1 | 24.2 | 82.3 | 60.4 | 86.4 | 79.6 | 74.1 |
| Operating cash flow as a percentage of net earnings | 245.0% | 212.0% | 174.0% | 160.0% | 156.0% | 177.0% | 147.0% |
| Free cash flow as a percentage of adjusted net earnings | 184.0% | 136.0% | 134.0% | 125.0% | 130.0% | 122.0% | 106.0% |
Cautionary Statement Regarding Forward-Looking Statements
Readers are cautioned that the statements contained in this document regarding expectations of our performance or other matters that may affect our business, results of operations, or financial condition are, or may be deemed to be, “forward-looking statements” as defined by the “safe harbor” provisions in the Private Securities Litigation Reform Act of 1995. Such statements are made in reliance on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of historical fact, included or incorporated in this document, including statements regarding our strategy, financial position, guidance, funding for continued operations, cash reserves, liquidity, projected costs, plans, projects, awards and contracts, and objectives of management, among others, are forward-looking statements. Words such as “expect,” “anticipate,” “should,” “believe,” “hope,” “target,” “continued,” “project,” “plan,” “goals,” “opportunity,” “appeal,” “estimate,” “potential,” “predict,” “demonstrates,” “may,” “will,” “might,” “could,” “intend,” “shall,” “possible,” “would,” “approximately,” “likely,” “outlook,” “schedule,” “on track,” “poised,” “pipeline,” and variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements are not guarantees of future performance, conditions or results. Forward-looking statements are based on management’s expectations, certain assumptions, and currently available information. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof and are based on various assumptions as to future events, the occurrence of which necessarily are subject to uncertainties. These forward-looking statements are made subject to certain risks, uncertainties, and other factors, which could cause CTS’ actual results, performance, or achievements to differ materially from those presented in the forward-looking statements. Examples of factors that may affect future operating results and financial condition include, but are not limited to: supply chain disruptions (including, but not limited to, the availability and cost of rare earth elements, minerals and metals); changes in the economy generally, including inflationary and/or recessionary conditions and increased tariffs, and in respect to the businesses in which CTS operates; unanticipated issues in integrating acquisitions; the funding of contracts by the U.S. Government; the results of actions to reposition CTS’ business; rapid technological change; general market conditions in the transportation, as well as conditions in the industrial, aerospace and defense, and medical markets; reliance on key customers; unanticipated public health crises, natural disasters or other events; environmental compliance and remediation expenses; the ability to protect CTS’ intellectual property; pricing pressures and demand for CTS’ products; risks associated with CTS’ international operations, including trade and tariff barriers, trade pacts, including the future of the USMCA, exchange rates and political and geopolitical risks (including, without limitation, the impact of tariffs on China, Canada and Mexico, and other nations, the potential impact of U.S./China relations and the impact of geopolitical conflicts may have on our business, results of operations and financial condition; write offs of goodwill on our balance sheet; changes in existing tax laws or adoption of new tax laws; the amount and timing of any share repurchases; and the effect of any cybersecurity incidents on our business. Many of these, and other risks and uncertainties, are discussed in further detail in Item 1A. of CTS's most recent Annual Report on Form 10-K and other filings made with the SEC. CTS undertakes no obligation to publicly update CTS’ forward-looking statements to reflect new information or events or circumstances that arise after the date hereof, including market or industry changes.
Contact
Ashish Agrawal
Vice President and Chief Financial Officer
CTS Corporation
4925 Indiana Avenue
Lisle, IL 60532 USA
+1 (630) 577-8800 ashish.agrawal@ctscorp.com www.ctscorp.com
CTS CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF
EARNINGS
- UNAUDITED
(In thousands, except per share amounts) www.ctscorp.com